Renaissance Technologies’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.3K Buy
8,350
+7,532
+921% +$159K ﹤0.01% 3072
2025
Q4
$22.7K Buy
+818
New +$36.6K ﹤0.01% 3139
2025
Q3
Sell
-348
Closed -$82.8K 3715
2025
Q2
$82.8K Buy
+348
New +$67.9K ﹤0.01% 3329
2024
Q4
Sell
-429
Closed -$122K 3740
2024
Q3
$122K Buy
+429
New +$135K ﹤0.01% 3225
2024
Q2
Sell
-228
Closed -$91K 3751
2024
Q1
$91K Sell
228
-54
-19% -$20.1K ﹤0.01% 3388
2023
Q4
$99K Buy
+282
New +$99.8K ﹤0.01% 3301
2023
Q1
Sell
-212
Closed -$404K 4211
2022
Q4
$404K Buy
212
+37
+21% +$14.6K ﹤0.01% 3071
2022
Q3
$97K Buy
175
+33
+23% +$25.9K ﹤0.01% 3605
2022
Q2
$107K Buy
142
+37
+35% +$58.1K ﹤0.01% 3833
2022
Q1
$361K Buy
105
+55
+110% +$144K ﹤0.01% 3382
2021
Q4
$152K Sell
50
-17
-25% -$78.9K ﹤0.01% 3601
2021
Q3
$435K Buy
+67
New +$578K ﹤0.01% 2941
2021
Q1
Sell
-39
Closed -$654K 3519
2020
Q4
$654K Buy
+39
New +$734K ﹤0.01% 2708
2020
Q3
Sell
-7
Closed -$181K 3523
2020
Q2
$181K Sell
7
-40
-85% -$1.13M ﹤0.01% 3180
2020
Q1
$1.02M Buy
+47
New +$751K ﹤0.01% 2410
2019
Q3
Sell
-16
Closed -$258K 3569
2019
Q2
$258K Sell
16
-29
-64% -$480K ﹤0.01% 3232
2019
Q1
$926K Sell
45
-72
-62% -$1.28M ﹤0.01% 2705
2018
Q4
$1.42M Buy
117
+99
+550% +$1.72M ﹤0.01% 2408
2018
Q3
$436K Buy
+18
New +$548K ﹤0.01% 2894

Other funds holding KALA

Renaissance Technologies's KALA Position: Q1 2026 in Review

Renaissance Technologies increased its KALA BIO (KALA) stake by 921% in Q1 2026, buying an estimated $159K and bringing the position to 8,350 shares worth $72.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

Renaissance Technologies first reported a position in KALA in Q3 2018 and has held it in 19 quarters since. The position peaked at $1.42M in Q4 2018. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • Renaissance Technologies held 8,350 shares of KALA BIO worth $72.3K as of Q1 2026.
  • Renaissance Technologies bought 7,532 KALA BIO shares in Q1 2026, an estimated $159K.
  • KALA BIO made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3072 holding.
  • Renaissance Technologies first reported a position in KALA BIO in Q3 2018 and has held it in 19 quarters since.
  • Renaissance Technologies's KALA BIO position peaked at $1.42M in Q4 2018.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.